| 11529341 |
Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation |
Chandregowda Venkateshappa, Jeyaraj D A, Muralidhar Pendyala, Dhanalakshmi Sivanandhan |
2022-12-20 |
| 11459338 |
Heterocyclic compounds as PRMT5 inhibitors |
Saravanan Vadivelu, Raghunadha Reddy Burri, Shivani Garapaty, Dhanalakshmi Sivanandhan, Manish Kumar Thakur +8 more |
2022-10-04 |
| 11426412 |
Imidazo-pyridine compounds as PAD inhibitors |
Gurulingappa Hallur, Athisayamani Jeyaraj Duraiswamy, Buchi Reddy Purra, N.V.S.K. RAO, Rajendra Kristam |
2022-08-30 |
| 11352322 |
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors |
Mahanandeesha S. HALLUR, Purushottam Dewang, Kannan Murugan, Durga Prasanna Kumar C. H., Pravin S. Iyer +7 more |
2022-06-07 |
| 11319326 |
Tricyclic fused derivatives of 1-(cyclo)alkyl pyrtdin-2-one useful for the treatment of cancer |
Saravanan Vadivelu, Murugan CHINNAPATTU, Pavan Kumar Gondrala, Dhanalakshmi Sivanandhan, Chandrika Mulakala |
2022-05-03 |
| 11267820 |
Tricyclic fused pyridin-2-one derivatives and their use as BRD4 inhibitors |
Saravanan Vadivelu, Manjunatha M. Ramaiah, Pavan Kumar Gondrala, Murugan CHINNAPATTU, Dhanalakshmi Sivanandhan +2 more |
2022-03-08 |